Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas

Expert Reviews in Molecular Medicine

Volumn 1, Issue 4, 1998, Pages 1-10

  Hviid, Lars ^a  

^a Rigshospitalet   (Denmark)

Author keywords

chondroitin sulphate A; CSA; endemic; immunity; malaria; PfEMP1; Plasmodium falciparum; vaccine

Indexed keywords

EID: 84874804996     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399498000179     Document Type: Article

References (39)

1. Kwiatkowski, D. et al. (1989) Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin. Exp. Immunol. 77, 361–366
2. Smith, T. et al. (1993) Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop. 54, 55–72
3. Daubersies, P.S. et al. (1996) Rapid turn-over of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am. J. Trop. Med. Hyg. 54, 18–26
4. Contamin, H.T. et al. (1996) Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am. J. Trop. Med. Hyg. 54, 632–643
5. Lines, J. and Armstrong, J.R.M. (1992) For a few parasites more: inoculum size, vector control and strain-specific immunity to malaria. Parasitol. Today 8, 381–383
6. Marsh, K. and Howard, R.J. (1986) Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231, 150–153
7. Berendt, A.R. et al. (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341, 57–59
8. Ockenhouse, C.F. et al. (1989) Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 243, 1469–1471
9. Robert, C.B. et al. (1995) Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res. Immunol. 146, 383–393
10. Treutiger, C.J. et al. (1997) PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat. Med. 3, 1405–1408
11. Baruch, D.I. et al. (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82, 77–87
12. Smith, J.D. et al. (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82, 101–110
13. Su, X. et al. (1995) The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82, 89–100
14. Roberts, D.J. et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357, 689–692
15. Bull, P.C. et al. (1998) Parasite antigens on the infected red cell are targets for naturally acquired immunity to malaria. Nat. Med. 4, 358–360
16. Brabin, B.J. (1983) An analysis of malaria in pregnancy in Africa. Bull. World Health Organ. 61, 1005–1016
17. Weinberg, E.D. (1984) Pregnancy-associated depression of cell-mediated immunity. Rev. Infect. Dis. 6, 814–831
18. McGregor, I.A. (1987) Thoughts on malaria in pregnancy with consideration of some factors which influence remedial strategies. Parasitolia 29, 153–163
19. Maubert, B., Guilbert, L.J. and Deloron, P. (1997) Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect. Immun. 65, 1251–1257
20. Fried, M. and Duffy, P.E. (1996) Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 272, 1502–1504
21. Reeder, J.C. et al. (1997) Identification of a var gene associated with the adherence of Plasmodium falciparum to chondroitin sulfate A (Abstract). BSP Malaria Meeting, Liverpool 15–17/09/97, Abstract 3.5
22. Egan, A.F. et al. (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173, 765–769
23. Connelly, M. et al. (1997) T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65, 5082–5087
24. Oeuvray, C. et al. (1994) Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84, 1594–1602
25. Bouharoun-Tayoun, H. et al. (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172, 1633–1641
26. Lunel, F. and Druilhe, P. (1989) Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect. Immun. 57, 2043–2049
27. Druilhe, P. and Perignon, J.-L. (1997) A hypothesis about the chronicity of malaria infection. Parasitol. Today 13, 353–357
28. Staalsoe, T. and Hviid, L. (1998) The role of variant-specific immunity in asymptomatic infections: maintaining a fine balance. Parasitol. Today 14, 177–178
29. Marsh, K. (1992) Malaria - a neglected disease? Parasitology 104, S53-S69
30. Baird, J.K. et al. (1991) Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am. J. Trop. Med. Hyg. 45, 65–76
31. Baird, J.K. et al. (1993) Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am. J. Trop. Med. Hyg. 49, 707–719
32. Baird, J.K. (1995) Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11, 105–111
33. Kwiatkowski, D. et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201–1204
34. Kurtzhals, J.A. et al. (1998) Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351, 1768–1772
35. Carlson, J. et al. (1990) Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457–1460
36. Marsh, K. and Snow, R.W. (1997) 30 years of science and technology: the example of malaria. Lancet 349, (suppl. III), 1–2
37. Galvez, A. et al. (1998) Publication rates reveal trends in microbiological research. ASM News 64, 269–275
38. Stoute, J.A. et al. (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336, 86–91
39. Greenwood, B.M., Marsh, K. and Snow, R. (1991) Why do some children develop severe malaria? Parasitol. Today 7, 277–281